These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31919080)

  • 1. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure.
    Robach P; Gammella E; Recalcati S; Girelli D; Castagna A; Roustit M; Lundby C; Lundby AK; Bouzat P; Vergès S; Séchaud G; Banco P; Uhr M; Cornu C; Sallet P; Cairo G
    Haematologica; 2021 Feb; 106(2):384-390. PubMed ID: 31919080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.
    Breenfeldt Andersen A; Bonne TC; Bejder J; Jung G; Ganz T; Nemeth E; Olsen NV; Huertas JR; Nordsborg NB
    Am J Physiol Regul Integr Comp Physiol; 2021 Aug; 321(2):R152-R161. PubMed ID: 34160288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
    Zaman BA; Rasool SO; Abdo JM
    Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
    Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
    Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia.
    Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
    J Nutr; 2021 Jul; 151(7):1824-1833. PubMed ID: 33982118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
    Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D
    Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent.
    Tomczyk M; Kortas J; Flis D; Kaczorowska-Hac B; Grzybkowska A; Borkowska A; Lewicka E; Dabrowska-Kugacka A; Antosiewicz J
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythroferrone inhibits the induction of hepcidin by BMP6.
    Arezes J; Foy N; McHugh K; Sawant A; Quinkert D; Terraube V; Brinth A; Tam M; LaVallie ER; Taylor S; Armitage AE; Pasricha SR; Cunningham O; Lambert M; Draper SJ; Jasuja R; Drakesmith H
    Blood; 2018 Oct; 132(14):1473-1477. PubMed ID: 30097509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
    Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
    Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythroferrone is not required for the glucoregulatory and hematologic effects of chronic erythropoietin treatment in mice.
    Coffey R; Sardo U; Kautz L; Gabayan V; Nemeth E; Ganz T
    Physiol Rep; 2018 Sep; 6(19):e13890. PubMed ID: 30315639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly.
    Gammella E; Diaz V; Recalcati S; Buratti P; Samaja M; Dey S; Noguchi CT; Gassmann M; Cairo G
    Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R330-5. PubMed ID: 25519735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor.
    Kralova B; Sochorcova L; Song J; Jahoda O; Hlusickova Kapralova K; Prchal JT; Divoky V; Horvathova M
    Am J Hematol; 2022 Oct; 97(10):1286-1299. PubMed ID: 35815815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples.
    Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
    J Nutr; 2021 Sep; 151(9):2590-2600. PubMed ID: 34236433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietic regulators of iron metabolism.
    Ganz T
    Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.
    Srole DN; Ganz T
    J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin as a potential biomarker for blood doping.
    Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
    Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic intermittent hypobaric hypoxia improves iron metabolism disorders via the IL-6/JAK2/STAT3 and Epo/STAT5/ERFE signaling pathways in metabolic syndrome rats.
    Cui F; Sun J; Mi H; Li B; Tang L; Wang R; Du Y; Guo B; Li Y; Shi M
    J Trace Elem Med Biol; 2023 Sep; 79():127259. PubMed ID: 37413927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?
    Bahr TM; Ward DM; Jia X; Ohls RK; German KR; Christensen RD
    Blood Cells Mol Dis; 2021 May; 88():102536. PubMed ID: 33450539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
    Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
    PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.
    Miura S; Kobune M; Horiguchi H; Kikuchi S; Iyama S; Murase K; Goto A; Ikeda H; Takada K; Miyanishi K; Kato J
    Blood Cells Mol Dis; 2019 Sep; 78():1-8. PubMed ID: 31082798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.